Tango Therapeutics Inc (TNGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Sales | 17,138 | 16,705 | 15,955 | 15,079 | 14,156 |
| Cost of Goods | 7,612 | 7,362 | 7,083 | 6,736 | 6,283 |
| Gross Profit | 9,526 | 9,343 | 8,872 | 8,343 | 7,873 |
| Operating Expenses | 9,692 | 9,405 | 8,586 | 8,809 | 7,978 |
| Operating Income | 446 | 300 | 369 | 269 | 178 |
| Interest Expense | 525 | 533 | 542 | 592 | 526 |
| Other Income | 44 | 47 | -638 | 37 | -45 |
| Pre-tax Income | -35 | -186 | -811 | -286 | -393 |
| Income Tax | 68 | 49 | 64 | 98 | 46 |
| Net Income Continuous | -103 | -235 | -875 | -384 | -439 |
| Net Income | $-103 | $-235 | $-875 | $-384 | $-439 |
| EPS Basic Total Ops | -0.24 | -0.27 | -0.42 | -1.35 | N/A |
| EPS Basic Continuous Ops | -0.02 | -0.05 | -0.20 | -0.53 | N/A |
| EPS Diluted Total Ops | -0.24 | -0.27 | -0.42 | -1.35 | N/A |
| EPS Diluted Continuous Ops | -0.02 | -0.05 | -0.20 | -0.53 | N/A |
| EBITDA(a) | $1,333 | $1,205 | $1,272 | $269 | $178 |